Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality

Article Urology & Nephrology

Impact of the evolving United States Preventative Services Task Force policy statements on incidence and distribution of prostate cancer over 15 years in a statewide cancer registry

Seong H. Jeong et al.

Summary: The study found that the incidence of prostate cancer in Pennsylvania has decreased over the past 15 years, but there has been an increase in distant cancer rates in recent years, potentially linked to the USPSTF recommendations.

PROSTATE INTERNATIONAL (2021)

Add to Collection

Editorial Material Obstetrics & Gynecology

Association of Medicaid expansion with mortality from gynecologic cancers

Benjamin B. Albright et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Meeting Abstract Oncology

Association of reductions in PSA screening across states with increased metastatic prostate cancer in the United States.

Vidit Sharma et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Urology & Nephrology

Trends for Stage and Grade Group of Prostate Cancer in the US (2010-2016)

Ken Schmanke et al.

Summary: Following the 2011/2012 update, there has been a decrease in overall prostate cancer incidence but an increase in the rate of metastatic disease, especially among men aged 70 and older, in the US from 2010 to 2016.

UROLOGY (2021)

Add to Collection

Article Urology & Nephrology

Impact on prostate cancer clinical presentation after non-screening policies at a tertiary-care medical center- a retrospective study

Tarek Ajami et al.

Summary: After the 2012 recommendation by the US Preventive Task Force, there was a significant increase in positive biopsy rate, higher clinical stages, and increased metastatic rates. These results indicate an impact on prostate cancer screening following the recommendation.

BMC UROLOGY (2021)

Add to Collection

Article Oncology

Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation

Kevin H. Kensler et al.

Summary: The frequency of prostate cancer screening varies by race and ethnicity, with a steeper decline in PSA testing among younger non-Hispanic Black men relative to non-Hispanic White men since 2012. The incidence rate ratio for localized prostate cancer modestly increased for non-Hispanic Black men compared to non-Hispanic White men after 2012.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Add to Collection

Article Health Policy & Services

Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey

Jarrett A. Johnson et al.

Summary: The study found that men surveyed in 2015 were less likely to report having undergone PSA testing compared to those in 2010, with foreign-born men and men belonging to all other racial categories showing significantly lower rates of PSA testing. Furthermore, compared to US-born and older non-Hispanic white men, foreign-born men and men of other races were less likely to utilize PSA testing.

JOURNAL OF COMMUNITY HEALTH (2021)

Add to Collection

Article Medicine, General & Internal